Finance

Lists
Why is CRDL down 8,27%?
Dive Deeper
CRDL:NASDAQ
Cardiol Therapeutics Inc
USD 0,93
-8,27%
(-0,083) 1D
USD 0,94
+2,00% (+0,018)
After hours
Closed: 5 Nov., 16:00:02 GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CRDL...
Open
USD 1,00
High
USD 1,03
Low
USD 0,92
Mkt. cap
161,75 m
Avg. vol.
1,23 m
Volume
733,81 k
52-wk high
USD 2,34
52-wk low
USD 0,88
Beta
1,03
Shares outstanding
116,82 m
No. of employees
18
Open
USD 1,00
High
USD 1,03
Low
USD 0,92
Mkt. cap
161,75 m
Avg. vol.
1,23 m
Volume
733,81 k
52-wk high
USD 2,34
52-wk low
USD 0,88
Beta
1,03
Shares outstanding
116,82 m
No. of employees
18
News stories
From web sources and news partners
About Cardiol Therapeutics Inc
CEODavid Elsley
Employees18
Founded2017
HeadquartersOakville, Ontario, Kanada
SectorHealth Care
IndustryPharmaceutical industry
Websitecardiolrx.com
Analyst
Recommendation
Action
Price target
Projected
Date
No analyst ratings found.
Previous reportsAll values in CAD
Loading Previous Earnings...
Revenue
Net income
All values in CAD
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
4,79 m
2,74 m
4,95 m
3,20 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5,39 m
5,29 m
4,76 m
4,74 m
Operating expense
10,18 m
8,03 m
9,71 m
7,94 m
Total operating expenses
10,18 m
8,03 m
9,71 m
7,94 m
Operating income
-10,18 m
-8,03 m
-9,71 m
-7,94 m
Other non operating income
-
951,74 k
-1,53 m
1,35 m
EBT including unusual items
-9,96 m
-7,21 m
-10,82 m
-6,08 m
EBT excluding unusual items
-9,96 m
-7,21 m
-10,82 m
-6,08 m
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-9,96 m
-7,21 m
-10,82 m
-6,08 m
Net profit margin
-
-
-
-
Earnings per share
-0,12
-0,07
-0,10
-0,05
Interest and investment income
122,26 k
175,21 k
200,72 k
201,33 k
Interest expense
-
-
-
-
Net interest expenses
122,26 k
175,21 k
200,72 k
201,33 k
Depreciation and amortization charges
-
-
-
-
EBITDA
-10,17 m
-8,02 m
-9,70 m
-7,93 m
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme